Radiolabeled Somatostatin Analogues Therapy in Advanced Neuroendocrine Tumors: A Single Centre Experience

The aim of this study was to assess the efficacy of PRRT in patients with advanced neuroendocrine tumors (NETs). Patients and Methods. From January 2007 to August 2011, we enrolled 65 patients (m/f 38/27; mean age 65 years, range 33–83) with advanced NETs having enhanced SSTR expression, treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Filice, A., Fraternali, A., Frasoldati, A., Asti, M., Grassi, E., Massi, L., Sollini, M., Froio, A., Erba, P. A., Versari, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425839/
https://www.ncbi.nlm.nih.gov/pubmed/22934111
http://dx.doi.org/10.1155/2012/320198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425839/
https://www.ncbi.nlm.nih.gov/pubmed/22934111
http://dx.doi.org/10.1155/2012/320198

Ejemplares similares